Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
Conditions
- Acute Leukemia of Ambiguous Lineage
- Acute Myeloid Leukemia
- Myeloid Neoplasm
Interventions
- DRUG: Cladribine
- DRUG: Cytarabine
- BIOLOGICAL: Granulocyte Colony-Stimulating Factor
- DRUG: Mitoxantrone Hydrochloride
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
Sponsor
University of Washington
Collaborators